AstraZeneca Stock Nears Buy Point After Long Run In Declining Market
AstraZeneca (AZN) is Thursday's pick for IBD 50 Growth Stocks To Watch as the biopharmaceutical name is holding up relatively well in a declining market. AstraZeneca stock is nearing a buy point after climbing for seven straight weeks. The IBD 50 drug stock is rising around 1.2% Thursday and outpacing the struggling major indexes. Some investors have looked outside the…